A randomised trial of the safety and immunogenicity of low dose haemophilus conjugate vaccine in healthy infants at 6,10, and 14 weeks of age

Simple item page
dc.contributor.authorNicol, Mark. Patrick.
dc.date.accessioned2019-02-01T08:04:36Z
dc.date.available2019-02-01T08:04:36Z
dc.date.issued2002-09-01
dc.descriptionA Research Report submitted to the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, in partial fulfilment of the requirements for the degree of Master of Medicine in the branch of Medical Microbiologyen_ZA
dc.description.abstractBackground Despite their proven efficacy, Haemophilus influenzae type b (Hib) conjugate vaccines are not given to most children in the developing world in the face of an estimated global Hib disease burden of nearly 2 million cases per annum. A major barrier to the introduction of the vaccine would be overcome by diluting the vaccine tenfold in DTP. We report a randomised trial comparing the use of Hib conjugate vaccine diluted tenfold in a multidose vial of DTP, with that of the full Hib dose.en_ZA
dc.description.librarianIT2019en_ZA
dc.identifier.urihttps://hdl.handle.net/10539/26366
dc.language.isoenen_ZA
dc.subject.meshImmunogenicity, Vaccine
dc.subject.meshHaemophilus
dc.subject.meshVaccines, Conjugate
dc.subject.meshInfant
dc.subject.meshHaemophilus influenzae
dc.titleA randomised trial of the safety and immunogenicity of low dose haemophilus conjugate vaccine in healthy infants at 6,10, and 14 weeks of ageen_ZA
dc.typeThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Mark Patric Nicol.pdf
Size:
1.17 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
ETD Collection